EffePharm Certified to cGMP Standards, A Milestone in Quality Excellence

Shanghai, China – August 28, 2025. EffePharm, a leader in high-potency bioactive ingredients, today announced a significant milestone: its manufacturing facility has been awarded Current Good Manufacturing Practice (cGMP) certification by NSF International, a globally recognized authority in public health and safety standards. This certification affirms EffePharm’s unwavering commitment to quality, safety, and innovation, further strengthening its role as a trusted global partner in liposomal technology and contract manufacturing.

As global demand for precision-engineered liposomal supplements and healthy aging bioactives continues to grow, EffePharm’s cGMP compliance sets a new standard, ensuring every batch of ingredients meets the highest international requirements for consistency, purity, and efficacy.

What is cGMP, and Why Does It Matter for Supplements?

Beyond Basic GMP – The Gold Standard for Safe, Reliable Manufacturing

Good Manufacturing Practice (GMP) has long served as the foundation of quality assurance in manufacturing, establishing the baseline standards needed to ensure consistent product quality. Current Good Manufacturing Practice (cGMP), however, raises the bar by emphasizing continuous improvement. Unlike static GMP guidelines, cGMP evolves in response to advances in science, regulatory requirements, and emerging risks, ensuring manufacturers remain aligned with the highest industry standards.

For both consumers and brand partners, cGMP certification represents a mark of trust, especially vital for complex formulations such as liposomal supplements. These advanced products, which utilize lipid-based carriers to enhance nutrient absorption, necessitate precise control over factors such as particle size, encapsulation efficiency, and contamination risk. By adhering to cGMP, every stage of production—from raw material sourcing to final product testing—is carefully managed, ensuring that what appears on the label is exactly what’s delivered in the bottle.

Liposomal Innovation Meets cGMP Excellence: EffePharm’s LipoAvail™ Technology

Precision Engineering Powers Next-Gen Nutrient Delivery

At the core of EffePharm’s success is its proprietary LipoAvail™ liposomal delivery system, a game-changer for enhancing the bioavailability of compounds that are difficult to absorb, such as curcumin, PEA, and NAD. Unlike conventional supplements, LipoAvail™ utilizes liposomes to shield actives and transport them directly into cells, thereby dramatically enhancing absorption.

To fully comply with cGMP standards, EffePharm implemented comprehensive, multi-dimensional upgrades across its operations. On the facilities side, state-of-the-art cleanrooms were established to ensure the purity and stability of high-potency actives throughout production. From a systems perspective, a digital quality management system (QMS) was developed around core technologies such as LipoAvail™ liposomal processes, enabling precise monitoring and reproducible control of critical quality attributes (CQAs) for each batch—including encapsulation efficiency, particle size distribution, and product stability. On the human resources side, company-wide GMP training and assessment programs were introduced, embedding the principle that “quality begins with design” into every stage of R&D and manufacturing. These investments collectively provide a robust foundation for EffePharm’s ongoing innovation and product excellence.

“LipoAvail™ is more than a technology; it represents our commitment to precision and high efficacy,” said Dr. Jianjun Yu, R&D Vice President at EffePharm. “Earning cGMP certification confirms that we can reliably scale this innovation, transforming laboratory breakthroughs into products that consistently deliver results for brands and consumers around the globe.”

Empowering Global Partners Through Liposomal Innovation and Clinically Proven Ingredients

cGMP Compliance Opens Doors for End-to-End Contract Manufacturing

For brands seeking a trusted partner in liposomal innovation, EffePharm’s cGMP certification further elevates its capabilities. The company offers full-service liposomal contract manufacturing, supporting clients through every stage, from early formulation development to large-scale commercial production. Whether developing a custom liposomal vitamin for a wellness brand, a targeted nutritional delivery system, or next-generation NAD⁺ boosters like UTHEVER® NMN and UthPeak® NMNH (reduced NMN), EffePharm’s cGMP-compliant processes ensure speed, efficiency, and consistent quality.

EffePharm also strengthens its position as a leader in liposomal food supplements, with a portfolio that includes top-selling products such as liposomal vitamin C, curcumin, and NAD. With cGMP certification, global partners can be confident that every product, from clinically validated active ingredients to finished formulations, meets the most stringent international standards, from FDA guidelines in the U.S. to EFSA regulations in the EU, supporting seamless access to global markets.

“Traceability is essential in today’s supply chains,” said Addy Gao, Marketing Director at EffePharm. “With cGMP, we provide clients with complete end-to-end documentation—from raw material Certificates of Analysis (CoAs) to batch release reports—so they can confidently bring products to market, knowing every step adheres to the highest standards. Our commitment to clinically proven ingredients like UTHEVER® and UthPeak® ensures that innovation is backed by science, delivering real results for brands and consumers worldwide.”

About EffePharm:

Founded in 2017, EffePharm is a biotech company that offers science-backed bioactive ingredients to address unmet nutritional needs, empowering individuals to take more control of their health and thrive at every stage of life.

EffePharm advocates for innovative bioscience applications, increased accessibility of nutrition, and improved quality of life. Committed to delivering efficacy-verified products to the market, EffePharm has established a portfolio of over 3,000 business partners worldwide, benefiting millions of consumers as they thrive throughout their health and nutrition journeys.